Opendata, web and dolomites
ASTELLAS PHARMA EUROPE LTD (United Kingdom): list of projects
The following table shows the list of Horizon 2020 projects developed by "ASTELLAS PHARMA EUROPE LTD". Projects are ordered by starting date.
Click on table headers to rearrange data.
| # | acronym | programme | role | EC contrib. | start | views |
|---|---|---|---|---|---|---|
| 1 | CLOSPORE | H2020-EU.1.3.1. | partner | 0.00 | 2015-01-01 | 804 |
| 2 | ADAPT-SMART | H2020-EU.3.1.7.13. | participant | 0.00 | 2015-07-01 | 713 |
| totale | 0.00 | |||||
Network analysis
This organization collaborated with partners in 13 countries.
CLOSPORE
Within the project CLOSPORE this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| partner | FI | HKScan Ltd (OTH) | |
| partner | UK | Ipsen Pharmaceuticals (OTH) | |
| partner | FI | Snellmanin Lihanjalostus Oy (OTH) | |
| partner | FI | Saarioinen (PRC) | |
| partner | FI | Atria Finland Ltd (PRC) | |
| participant | UK | GBL | Green Biologics Ltd. (PRC) |
| partner | FR | BIOMERIEUX SA (PRC) | |
| partner | UK | LANZATECH | LANZATECH UK LTD (PRC) |
| participant | PT | FCT/UNL | UNIVERSIDADE NOVA DE LISBOA (HES) |
| participant | NL | PURAC BIO | PURAC BIOCHEM BV (PRC) |
| partner | FR | METEX | METABOLIC EXPLORER SA (PRC) |
| participant | NL | WR | STICHTING WAGENINGEN RESEARCH (REC) |
| participant | NL | NIZO FOOD RESEARCH BV | NIZO FOOD RESEARCH BV (PRC) |
| participant | PT | ITQB | INSTITUTO DE TECNOLOGIA QUIMICA E BIOLOGICA - UNIVERSIDADE NOVA DE LISBOA (HES) |
| coordinator | UK | UoN | THE UNIVERSITY OF NOTTINGHAM (HES) |
| participant | FR | IPP | INSTITUT PASTEUR (REC) |
| participant | FI | UH | HELSINGIN YLIOPISTO (HES) |
ADAPT-SMART
Within the project ADAPT-SMART this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | CH | SHIRE | SHIRE INTERNATIONAL GMBH (PRC) |
| participant | UK | AbbVie | AbbVie Ltd (PRC) |
| participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
| participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
| participant | FR | Lysogene | LYSOGENE (PRC) |
| participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
| participant | NL | ZIN | ZORGINSTITUUT NEDERLAND (PUB) |
| participant | FR | IPSEN | IPSEN INNOVATION SAS (PRC) |
| participant | FR | HAS | HAUTE AUTORITE DE SANTE (PUB) |
| participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
| participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
| participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
| participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
| participant | BE | Amgen | AMGEN (PRC) |
| participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
| participant | UK | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
| coordinator | NL | LYGATURE | STICHTING LYGATURE (OTH) |
| participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
| participant | DE | Bayer | Bayer Pharma AG (PRC) |
| participant | US | MIT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (HES) |
| participant | UK | PFIZER | PFIZER LIMITED (PRC) |
| participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
| participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
| participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | DK | DHMA | SUNDHEDSSTYRELSEN (PUB) |
| participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
| participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
| participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
| participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
| participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
| participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
| participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
| participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
| participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |